Conventional implants were used by orthopedic surgeons previously to fix internal fixation for years. These implants have required a lot of development over the decades. Regardless it’s wide spread use, there are some problems associated with conventional implants which include the potential for long term relocation, stress shielding, breakage, reaction of the material, interference with the imaging devices and restricted growth in young patients. Recently, many bioresorbable implants have been made available as a feasible alternative to various indications. These bioresorbable implants dissolve in the human body and then get replaced by the natural bones. The implants which are somewhat large, interconnecting porous assembly is needed so that it can be integrated with the implant for better vascularization. By the additive manufacturing technology, this interconnecting porous structure can be manufactured directly.
There are many factors which are driving the bioresorbable implants market like increasing incidences of chronic diseases, rising geriatric population, increasing incidences of road accidents growing disposable incomes and high level of healthcare. Additionally, the applications are increasing in medical and dental streams which are boosting the bioresorbable implants market.One of the most restraining factors of bioresorbable polymers is their inherent low strength compared to metals. Major tissue reactions have been reported in some cases. However, the time consuming approval processes of bioresorbable implants by the regulatory authorities, the reimbursement and the high cost of treatment will affect the bioresorbable implants market negatively.
Geographically, the implantable medical devices market has been segmented into five regions: North America, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for bioresorbable implants is further categorized into indications and material segments are considered in the study.
From the global perspective, North America accounts for the largest market share for bioresorbable implants owing to the rising demand of bioresorbable implants owing to the increasing incidences of orthopedic and dental ailments. High adoption rate of bioresorbable implants in North America probably will help the region to retain the position of the leading region in the forecast years. However, other regions like Asia Pacific, Middle East & Africa are expected to be probable bioresorbable implants markets in coming years. Across emerging markets, Asia Pacific and Latin America, the bioresorbable implants market is expected to have a strong growth in the forecast years. Due to the extensive awareness about the bioresorbable implants, these areas are most likely to be potential markets for bioresorbable implants.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/14074
Currently, the global bioresorbable implants market is highly competitive owing to the involvement of many established players. Some of the key players in the global bioresorbable implants market are Bioretec, DePuy Synthes, Stryker, Smith & Nephew, Biomet, Medtronic and Nu Vasive.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/14074